These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Does quality of life outweigh the cardiovascular risks of stimulant medication in a child with ADHD and hypertrophic cardiomyopathy? Senderey E; Sousa J; Stavitsky M BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978610 [TBL] [Abstract][Full Text] [Related]
46. ADHD, stimulant treatment in childhood and subsequent substance abuse in adulthood - a naturalistic long-term follow-up study. Dalsgaard S; Mortensen PB; Frydenberg M; Thomsen PH Addict Behav; 2014 Jan; 39(1):325-8. PubMed ID: 24090624 [TBL] [Abstract][Full Text] [Related]
47. Sleep in children with attention-deficit hyperactivity disorder (ADHD): a review of naturalistic and stimulant intervention studies. Cohen-Zion M; Ancoli-Israel S Sleep Med Rev; 2004 Oct; 8(5):379-402. PubMed ID: 15336238 [TBL] [Abstract][Full Text] [Related]
48. The impact of stimulants on a clinical measure of attention in children with ADHD. Gardner BK; Sheppard DM; Efron D Child Neuropsychol; 2008 Mar; 14(2):171-86. PubMed ID: 17852126 [TBL] [Abstract][Full Text] [Related]
49. The diagnostic and pharmacological variances of bipolar disorder versus attention-deficit/hyperactivity disorder. Lysne DH; Peterson T; Erickson K; Uriell M Am J Psychiatry; 2006 Dec; 163(12):2196; author reply 2196. PubMed ID: 17151181 [No Abstract] [Full Text] [Related]
50. Clinical suggestions for management of stimulant treatment in adolescents. Weiss M; Jain U; Garland J Can J Psychiatry; 2000 Oct; 45(8):717-23. PubMed ID: 11086554 [TBL] [Abstract][Full Text] [Related]
51. CNS stimulant controversies. Levy F Aust N Z J Psychiatry; 1989 Dec; 23(4):497-502. PubMed ID: 2575372 [TBL] [Abstract][Full Text] [Related]
52. Stimulant treatment for ADHD may not increase risk of substance abuse. Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888 [No Abstract] [Full Text] [Related]
53. Treating the childhood bipolar controversy: a tale of two children. Carlson GA Am J Psychiatry; 2009 Jan; 166(1):18-24. PubMed ID: 19122014 [No Abstract] [Full Text] [Related]
55. Long-term safety of stimulant medications used to treat children with ADHD. Lerner M; Wigal T Pediatr Ann; 2008 Jan; 37(1):37-45. PubMed ID: 18240852 [No Abstract] [Full Text] [Related]
56. Datapoints: trends in ADHD and stimulant use among adults: 1995-2002. Robison LM; Sclar DA; Skaer TL Psychiatr Serv; 2005 Dec; 56(12):1497. PubMed ID: 16339610 [No Abstract] [Full Text] [Related]
57. ADHD-juvenile bipolar disorder: mimics and chameleons! Naguy A World J Pediatr; 2018 Dec; 14(6):525-527. PubMed ID: 29446039 [No Abstract] [Full Text] [Related]
59. Considerations in the Use of Stimulants in Sport. Reardon CL; Factor RM Sports Med; 2016 May; 46(5):611-7. PubMed ID: 26712509 [TBL] [Abstract][Full Text] [Related]
60. Acute Dystonia After Stimulant Discontinuation in 2 ADHD Children Receiving Aripiprazole. Párraga HC; Sherman BC J Clin Psychopharmacol; 2015 Aug; 35(4):480-1. PubMed ID: 26035051 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]